Polly review

Review Polly as the continuation of Piper

The former Piper domain redirects to Polly, and the official rebrand explanation identifies the same continuing treatment and account arrangements. The current catalogue names compounded semaglutide and tirzepatide, alongside separate wellness prescriptions. One current service should be compared under its present identity. ^{[1] [2]}

Polly provides access and administration; independent clinicians determine treatment and pharmacies dispense it. The homepage lists possible partners including Hallandale and VialsRx. Confirm the actual provider and dispenser rather than treat a network description as your completed care assignment. ^{[2] [3]}

Compare the actual care relationship in our GLP-1 provider comparisons.

Separate a monthly plan from a prepaid equivalent

Semaglutide is listed at $179 month to month, with $166 and $135 monthly equivalents for three and six months. Tirzepatide lists $279, $216 and $199 respectively. The longer terms are paid upfront; the tirzepatide article explicitly gives a $1,194 six-month charge. ^{[7] [11] [12]}

The advertised inclusion covers consultation, medication, necessary supplies, shipping and continuing support. Confirm the actual selected total and usable supply rather than assume every multi-month equivalent is an installment. A financing provider does not remove the underlying purchase commitment. ^[9]

Separate the real paid amounts in the complete GLP-1 cost planner.

Match the formulation to the medical rationale

The product articles explain that B12 or glycine may be included depending on the pharmacy and prescription. Neither added ingredient nor a familiar active ingredient establishes superiority or the same finished product as an approved brand. The pages acknowledge the compounds are not FDA-approved. ^{[13] [14]}

FDA recommends compounded GLP-1 medicines only for needs an approved drug cannot meet and identifies dosing and quality concerns. Ask the clinician to establish that rationale and the exact preparation. The pharmacy label, concentration and individualized directions must match the prescription; a low price does not settle the clinical decision. ^[15]

Keep the finished product specific with preparation and route differences.

Distinguish measured outcomes with lean mass during GLP-1 treatment.

Approval does not mean next-day arrival

The payment FAQ describes a temporary authorization, converted to a final charge after approval. A denied or incomplete process releases the hold on the bank’s timetable. That is distinct from refunding an approved prescription later. ^[6]

The shipping policy separates provider review, pharmacy preparation and expedited carrier transit, with dispatch generally within two to four business days after approval and preparation. A next-day-air headline is not a guarantee that an initial order arrives tomorrow. ^[5]

For another approval and refill arrangement, read our OrderlyMeds review.

The refund cutoff is pharmacy submission

The formal policy generally permits cancellation before an order reaches the pharmacy and excludes it after transmission. It lists specific ineligibility, damage and billing-error exceptions, while ordinary unused time is not prorated. ^[4]

Later help pages discuss discretionary unused-supply adjustments and reverting an early-ended discounted plan to standard pricing for supply received. They do not establish a universal refundable first month or a guaranteed unused balance. Obtain the actual selected exit conditions before paying for a longer term. ^{[7] [8]}

For a different paid-term and refund model, compare our Raeliva review.

Confirm the next charge and the care contact

The general auto-refill article describes processing approximately every 25 days, allowing time for review and fulfillment. Confirm the applicable billing date and whether a pause or cancellation has been accepted before another order reaches the pharmacy. A calendar-month assumption may be wrong. ^[8]

I would compare Polly on a defined prescription, useful clinical access and an affordable full commitment. Its additional NAD+ and sermorelin offerings should be separate clinical decisions, not presumed parts of a weight-care plan or proof of better outcomes from combining prescriptions. ^[2]

Consider continuing care alongside the evidence after GLP-1 treatment stops.

For a different appointment-based service and separate medicine bill, read our PlushCare review.

For a contrasting prescription, pharmacy and paid-term arrangement, read our Pomegranate Health review.

Understanding the cost

Semaglutide $179 month to month, with $166/$135 monthly equivalents for three/six months. Tirzepatide $279 monthly, with $216/$199 equivalents; the six-month total is explicitly $1,194 upfront. Multi-month plans are paid in advance; confirm actual selected totals, supplied quantity, auto-refill timing and early-exit adjustments. ^{[7] [8] [11] [12]}